A case of irreversible alopecia associated with ribavirin and peg-interferon therapy

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 1, 2010, Pages 122-123

  Shafa, Shervin ^a   Borum, Marie L ^a   Igiehon, Enaruna ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PEGINTERFERON; RIBAVIRIN;

AGED; ALOPECIA; CASE REPORT; COMBINATION CHEMOTHERAPY; DRUG WITHDRAWAL; FEMALE; HEPATITIS C; HUMAN; LETTER; LIVER FIBROSIS; MONOTHERAPY; PRIORITY JOURNAL; TREATMENT RESPONSE;

AGED; ALOPECIA AREATA; ANTIVIRAL AGENTS; DRUG ERUPTIONS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; POLYETHYLENE GLYCOLS; RIBAVIRIN;

EID: 74349129252     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32832be7a5     Document Type: Letter

References (2)

1. Kartal ED, Alpat SN, Ozgunes I, Usluer G. Reversible alopecia universalis secondary to PEG-interferon [alpha]-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Eur J Gastroenterol Hepatol 2007; 19:817-820.
2. Khokar OS, Lewis JH. Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time? Dig Dis Sci 2007; 52:1168-1176.